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Breast cancer tumours are embedded in a collagen I rich extracellular matrix (ECM) network where nutrients are scarce due
to limited blood flow and elevated tumour growth. Metabolic adaptation is required for breast cancer cells to endure these
conditions. Here, we demonstrated that the presence of ECM supported the growth of invasive breast cancer cells, but not
non-transformed mammary epithelial cells, under amino acid starvation, through a mechanism that required ECM uptake.
Importantly, we showed that this behaviour was acquired during carcinoma progression. ECM internalisation, followed by
lysosomal degradation, contributed to the upregulation of the intracellular levels of several amino acids, including tyrosine
and phenylalanine. Finally, we showed that cells on ECM had elevated tyrosine catabolism, leading to elevated fumarate
levels, potentially feeding into the tricarboxylic acid cycle. Interestingly, this pathway was required for ECM-dependent cell
growth under amino acid starvation, as the knockdown of HPDL, the third enzyme of the pathway, opposed cell growth on
ECM without affecting cell proliferation on plastic. Collectively, our results highlight that the ECM surrounding breast cancer
tumours represents an alternative source of nutrients to support cancer cell growth, by regulating phenylalanine and tyrosine
metabolism.
Introduction
Breast cancer is the most common type of cancer among women. Breast cancer progression starts from benign hyperplasia
of epithelial cells of the mammary duct, leading to atypical ductal hyperplasia and ductal carcinoma in situ (DCIS), where
cancer cells are surrounded by an intact basement membrane (BM). Eventually, the cells acquire the ability to break through the
BM, resulting in the invasive and metastatic cancer phenotype1. In breast cancer, high breast tissue density is associated with a
shift to malignancy and invasion2, 3. There is growing evidence indicating that the tumour microenvironment (TME) facilitates
tumour growth and survival4. The TME consists of a variety of cell types, including stromal cells, and extracellular matrix
(ECM). The ECM is a highly dynamic three-dimensional network of macromolecules providing structural and mechanical
support to the tissues while interacting with cells through different receptors5, 6.
Due to limited blood supply and elevated tumour growth rate, the TME is often deprived of nutrients, including glucose
and amino acids7, 8. One of the hallmarks of cancer is the reprogramming of energy metabolism, which provides metabolic
flexibility allowing tumour cells to adapt to different nutrient conditions9. This includes the ability of cancer cells to benefit
from alternative sources. Indeed, different studies showed that cancer cells benefit from extracellular proteins during food
scarcity10–12. In Ras-driven pancreatic ductal adenocarcinoma cells amino acid and glutamine starvation induced albumin
and collagen internalisation respectively, followed by lysosomal degradation and amino acid extraction11, 13–15. Serum and
growth factor starvation also stimulated normal mammary epithelial cells to internalise laminin, which resulted in an increase in
cellular amino acid content10. These studies prompted us to investigate how the internalisation of different components of the
ECM impinged on breast cancer cells’ metabolism and growth under amino acid starvation.
To determine whether the ECM surrounding breast cancer cells could provide a metabolically favourable microenvironment,
here we assessed the effect of the presence of ECM on breast cancer cell growth and metabolism under glutamine and full amino
acid starvation. We demonstrated that the growth of starved invasive breast cancer cells, but not normal mammary epithelial
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cells, was supported by the presence of different types of ECM. Indeed, Matrigel and collagen I promoted MDA-MB-231 cell
division and enhanced mTORC1 activity under amino acid starvation. Interestingly, this was dependent on ECM endocytosis
and not focal adhesion signalling. Moreover, metabolomics analyses showed higher amino acid content and upregulation of
phenylalanine and tyrosine metabolism during amino acid deprivation in cancer cells grown on ECM compared to plastic,
leading to an increase in fumarate content. Importanly, the down-regulation of an enzyme in this pathway (HPDL) completely
abrogated cell growth on collagen I under amino acid starvation, without affecting cell growth on plastic. Our data suggest that
ECM scavenging fuels invasive breast cancer cell growth by promoting phenylalanine and tyrosine metabolism.
Results
The ECM supported invasive breast cancer cell growth under starvation
To assess whether the presence of ECM could promote the survival or growth of invasive breast cancer cells under nutrient
deprivation, MDA-MB-231 cells were seeded under complete media, glutamine or amino acid deficiency and cell growth was
quantified on collagen I, Matrigel and plastic. MDA-MB-231 cells showed significantly higher cell number and growth rate in
the presence of collagen I and Matrigel compared to cells on plastic after eight days of starvation (Figure 1A-D). Our data
also indicated that in the absence of starvation cell growth was independent of the ECM, as there was no significant difference
in cell number on ECM compared to plastic in complete media (Figure S1A-B). To test the effect of glutamine and amino
acid deficiency on cell growth in a more physiological environment, MDA-MB-231 were seeded on cell-derived matrices
(CDMs) generated by either normal breast fibroblasts (NFs) or cancer-associated fibroblasts (CAFs) extracted from breast
tumours. CDMs are complex 3D matrices that recapitulate several features of native collagen-rich matrices16. Different studies
highlighted that the CDM produced by CAFs has different structure and composition compared to the CDM derived from
normal fibroblasts17, 18. Here, we showed that breast cancer cell growth was rescued by both NF and CAF generated CDM
under glutamine starvation, but only CAF CDM resulted in a significant increase in cell growth under amino acid deprivation
(Figure 1E-F). These data indicate that CAF-CDM provided a more favourable environment for cancer cells’ growth compared
to NF-CDM under amino acid deprivation. In parallel, to more closely reproduce the in vivo metabolic environment, we used a
physiological medium, Plasmax. Plasmax is designed to contain metabolites and nutrients at the same concentration of human
blood to avoid adverse effects of commercial media on cancer cells19. To simulate the TME starvation conditions, Plasmax
was diluted with PBS. Cell growth data demonstrated that, while cells on plastic were not able to grow in 25 % Plasmax, the
presence of collagen I and Matrigel resulted in a significant increase in cell numbers (Figure 1G). Moreover, the ECM had a
small but significant effect in promoting cell growth in full Plasmax media as well (Figure S1C), suggesting that under more
physiological conditions the ECM could support cell growth even in the absence of nutrient starvation. Taken together, these
data indicated that presence of ECM positively affected invasive breast cancer cell growth under nutrient depleted conditions.
To assess whether the ECM-dependent cell growth under starvation was a feature that was acquired during breast cancer
progression, we took advantage of the MCF10 series of cells lines20. This includes normal mammary epithelial cells (MCF10A),
non-invasive ductal carcinoma in-situ breast cancer cells (MCF10A-DCIS) and metastatic breast cancer cells (MCF10CA1). The
cells were seeded either on plastic, collagen I or Matrigel in glutamine or amino acid depleted media for eight days. In contrast
to invasive MDA-MB-231 cells (Figure 1), MCF10A cell growth pattern on collagen I and Matrigel under starvation was similar
to the one on plastic. Although cell number was higher on collagen I and Matrigel under amino acid starvation compared
to plastic (Figure 2A,C), there was no significant difference in the growth rate of MCF10A cells on either matrix (Figure
2B,D). Similarly, our data showed no significant changes in MCF10A-DCIS cell growth on collagen I or Matrigel in amino acid
depleted media compared to the plastic (Figure 2E-G). Interestingly, while collagen I was not able to increase MCF10A-DCIS
cell growth under glutamine deficiency (Figure 2E-F), cell number and growth rate at day eight post glutamine starvation
were significantly higher on Matrigel compared to plastic (Figure 2G-H). Consistent with our observation in MDA-MB-231
cells, the growth of metastatic MCF10CA1 cells was significantly promoted by both Matrigel and collagen I under glutamine
or amino acid starvation (Figure 2I-L). These data suggest that the ability of using ECM to compensate for soluble nutrient
starvation could have been gradually acquired during cancer progression and could be a defining feature of invasive growth in
advanced metastatic breast cancer.
Collagen I and Matrigel increased cell division under amino acid starvation
The ECM-dependent increase in cell number could be mediated by a stimulation of cell division or an inhibition of cell death,
or both. To investigate this, we performed 5-Ethynyl-2´-deoxyuridine (EdU) incorporation experiments, as this thymidine
analogue allows the identification of cells which passed through DNA synthesis and mitosis. Cells were starved for six days
and then incubated with EdU for 2 days. As shown in figure 3, both glutamine and amino acid starvation significantly reduced
the percentage of EdU positive cells on plastic, while the presence of collagen I (Figure 3A) or matrigel (Figure 3B) resulted
in a significant increase in EdU positive cells. Consistent with the proliferation data, the presence of ECM did not affect EdU
incorporation in complete media. To elucidate whether the ECM also played an anti-apoptotic role, cell death was assessed by
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Figure 1. The ECM rescued cell growth under star-
vation. MDA-MB-231 cells were seeded on plastic, (A-
B) 2mg/ml collagen I (coll I) or (C-D) 3mg/ml Matrigel
(Matr) for eight days under glutamine (Gln) and amino
acid (AA) starvation, fixed, stained with DRAQ5 and im-
aged with a Licor Odyssey system every two days up to
day eight. Signal intensity was calculated by Image Stu-
dio Lite software. MDA-MB-231 cells were seeded on
plastic, (E) NF-CDM or (F) CAF-CDM under Gln or AA
starvation for eight days, fixed and stained with Hoechst.
Images were collected by ImageXpress micro and anal-
ysed by MetaXpress software. (G) MDA-MB-231 cells
were seeded on plastic, 2mg/ml collagen I (coll I) or
3mg/ml Matrigel in Plasmax media diluted 1:4 in PBS
(25%) for eight days, fixed and stained with DRAQ5 and
quantified as in A. Values are mean ± SEM from three in-
dependent experiments (the black dots in the bar graphs
represent the mean of individual experiments). *p<0.05,
**p<0.001, ***p< 0.001, **** p<0.0001 (A-C-E-F-G)
2way ANOVA, Tukey’s multiple comparisons test. (B-
D) Kruskal-Wallis, Dunn’s multiple comparisons test.
measuring the percentage of cells positive for an apoptosis marker, activated caspase-3/7, after three and eight days of amino
acid starvation. Although the apoptosis rate increased between day three and day eight in both complete and amino acid-free
media, and amino acid starvation resulted in increased cell death, there were no significant difference between the apoptosis
rate on collagen I and Matrigel compared to plastic either at day 3 (Figure S3A) or day 8 (Figure S3B) in amino acid depleted
media. Thus, our data indicate that collagen I and Matrigel induced invasive breast cancer cell proliferation under amino acid
starvation, without having an anti-apoptotic effect.
Collagen I and Matrigel rescued mTORC1 activity in starved cells
The mammalian target of Rapamycin (mTOR) signalling pathway is a key regulator of anabolic and catabolic processes. The
presence of amino acids, glucose and growth factors activates mTOR complex 1 (mTORC1), which triggers downstream
anabolic signalling pathways. However, the lack of amino acids and growth factors deactivates mTORC1 and induces catabolism,
resulting in lysosome biogenesis and autophagy21. Therefore, we investigated whether higher proliferation rate of cells on
collagen I and Matrigel was accompanied by a higher mTORC1 activity in starved MDA-MB-231 cells. To do this, we examined
the phosphorylation the ribosomal subunit S6, a key signalling event downstream of mTORC1 activation. MDA-MB-231 cells
were starved for three days either on collagen I, Matrigel or plastic, fixed and stained for phospho-S6 (p-S6). Quantifying the
intensity of p-S6, as expected, demonstrated that amino acid starvation resulted in a significant reduction in mTORC1 activity
on plastic. Interestingly, the presence of ECM fully rescued mTORC1 activation under amino acid starvation (Figure 3C-D).
Together, we can speculate that ECM endocytosis and degradation might result in higher lysosomal amino acid concentrations,
supporting mTORC1 activation.
Inhibition of ECM internalisation opposed cell growth under amino acid starvation
It was previously shown that, under starvation, cancer cells relied on scavenging extracellular proteins to maintain their survival
and growth10, 15 . To examine whether invasive breast cancer cells had the ability to internalise ECM components under
starvation, we tracked the ECM journey inside the cells in the presence and absence of a lysosomal protease inhibitor (E64d), to
prevent lysosomal degradation. The uptake of fluorescently-labelled collagen I (Figure 4A) and Matrigel (Figure 4B) was
monitored in complete or amino acid depleted media. The quantification of collagen I and Matrigel uptake demonstrated
that, under all nutrient condition, MDA-MB-231 cells significantly accumulated higher amounts of collagen I and Matrigel
inside the cells when lysosomal degradation was inhibited (Figure 4A-B), indicating that ECM components undergo lysosomal
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Figure 2. The ability to use the ECM to promote cell growth was acquired during carcinoma progression. MCF10A, MCF10A-DCIS
and MCF10CA1 cells were seeded on plastic, (A-B-E-F-I-J) 2mg/ml collagen I (coll I) or (C-D-G-H-K-L) 3mg/ml Matrigel (Matr) for
eight or six days under glutamine (Gln) and amino acid (AA) starvation, fixed, stained with DRAQ5 and imaged with a Licor Odyssey system
on the indicated days post starvation. Signal intensity was calculated by Image Studio Lite software. Values are mean ± SEM from three
independent experiments (the black dots in the bar graphs represent the mean of individual experiments). *p<0.05, **p<0.001, **** p<0.0001
(A-C-E-G-I-K) 2way ANOVA, Tukey’s multiple comparisons test. (B-D-F-H-J-L) Kruskal-Wallis, Dunn’s multiple comparisons test.
Figure 3. Collagen I and Matrigel induced cell proliferation
and rescued mTORC1 activity under amino acid starvation.
MDA-MB-231 cells were seeded on plastic, (A-C) 2mg/ml col-
lagen I (coll I) or (B-D) 3mg/ml Matrigel under complete media
(Com), glutamine (Gln) or amino acid (AA) starvation. (A-B)
Cells were incubated with EdU at day six post starvation, fixed
and stained with Hoechst and Click iT EdU imaging kit at day
8. Images were collected by ImageXpress micro and analysed
by MetaXpress software. (C-D) Cells were fixed and stained
for p-S6 and nuclei at day three post starvation. Images were
collected by ImageXpress micro and analysed by Costume Mod-
ule Editor (CME) software. Values are mean ± SEM from three
independent experiments (the black dots represent the mean of
individual experiments). *p<0.05, **p<0.001, **** p<0.0001
Kruskal-Wallis, Dunn’s multiple comparisons test.
degradation following internalisation. We then wanted to investigate whether the ECM-dependent growth of cancer cells under
nutrient deficiency relied on ECM internalisation. To assess this, collagen I and Matrigel coated plates were treated with
10% glutaraldehyde to chemically crosslink the amine groups of ECM components. Our data confirmed that cross-linking
completely opposed collagen I and Matrigel internalisation (Figure 4C-D). Interestingly, while the growth of MDA-MB-231
cells was not affected by matrix cross-linking in complete media (Figure S4A), the lack of collagen I and Matrigel uptake
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due to cross-linking completely opposed cell growth under amino acid starvation (Figure 4E). High matrix cross-linking has
been shown to also oppose extracellular ECM degradation mediated by matrix metalloproteinases (MMPs)22, therefore we
wanted to determine whether the inhibition of ECM-dependent cell growth by cross-linked matrices was due to a reduction
in ECM degradation by MMPs. In agreement with previous reports showing that ECM internalisation was not dependent
on protease activity23, our data indicated that MMP inhibition by treatment with the broad spectrum inhibitor GM6001 did
not reduce collagen I and Matrigel uptake (Figure S5A). Consistent with this, protease inhibition did not affect cell growth
under amino acid starvation (Figure S5B-D). Furthermore, treatment with the lipid raft-mediated endocytosis inhibitor filipin
resulted in a reduction of matrigel internalisation (Figure 4F-G) and cell growth on matrigel under amino acid starvation, but
not in complete media or on plastic (Figure 4H, Figure S4B). Altogether, these results demonstrate that ECM internalisation
is necessary for ECM-dependent breast cancer cell growth under amino acid starvation.
Figure 4. ECM endocytosis was required for ECM-dependent cell growth under amino acid starvation. MDA-MB-231 cells were
plated under complete (Com) or amino acid depleted (AA) media on NHS-fluorescein labelled (A) 2mg/ml collagen I (coll I) or (B)
3mg/ml Matrigel coated dishes for three days, in the presence of the lysosomal inhibitor E64d (20µM) or DMSO (control). (C-D) 2mg/ml
collagen I (coll I) or 3mg/ml Matrigel coated dishes were treated with 10% glutaraldehyde for 30 mins or left untreated and labelled with
NHS-Fluorescein (green). Cells were plated on the cross-liked (x-linked) matrices for three days under amino acid (AA) starvation in the
presence of E64d (20µM). Cells were fixed and stained for actin (red) and nuclei (blue). Samples were imaged with a Nikon A1 confocal
microscope and ECM uptake index was calculated with image J. Bar, 30µm. About 150 cells per condition in three independent experiments
were analysed, the black dots represent the mean of individual experiments. **p<0.001, **** p<0.0001 Kruskal-Wallis, Dunn’s multiple
comparisons test. (E) MDA-MB-231 cells were seeded on untreated (control) or cross-linked (X-linked) 2mg/ml collagen I (coll I) or 3mg/ml
Matrigel under amino acid (AA) starvation for 8 days. Cells were fixed and stained with Hoechst. Images were collected by ImageXpress
micro and analysed by MetaXpress software. Values are mean ± SEM from three independent experiments. **** p<0.0001 2way ANOVA,
Tukey’s multiple comparisons test. (F-G) MDA-MB-231 cells were seeded on pH-rodo labelled 0.5mg/ml Matrigel (white) in the presence of
DMSO control, 2.5µg/ml or 5µg/ml filipin for 6 hrs, fixed and stained for β1 integrin (green) and nuclei (blu). Bar, 20µm. Images were
collected with an Opera Phenix miscroscope and analysed with Columbus software. Values are mean ±SEM from 5 independent experiments
(the black dots represent the mean of individual experiments). **p<0.001 Kruskal-Wallis, Dunn’s multiple comparisons (H) MDA-MB-231
cells were seeded on plastic or 3mg/ml Matrigel for 3 days in amino acid depleted media, in the presence of 5µg/ml filipin or DMSO control,
fixed and stained with Hoechst. Images were collected by ImageXpress micro and analysed by MetaXpress software. Values are mean ± SEM
from three independent experiments (the black dots represent the mean of individual experiments). *p<0.05, **** p<0.0001 Kruskal-Wallis,
Dunn’s multiple comparisons test.
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Inhibition of focal adhesion kinase did not affect ECM-dependent cell growth under starvation
ECM cross-linking has been shown to increase matrix stiffness, thereby affecting cell adhesion and integrin signalling23.
Binding of ECM components to the integrin family of ECM receptors induces the recruitment of focal adhesion (FA) proteins on
the integrin intracellular domain, triggering dowstream signalling pathways24, 25. Focal adhesion kinase (FAK) is a non-receptor
tyrosine kinase located in FAs involved in the regulation of several cell behaviours, including proliferation, migration, and
survival. FAK is also over-expressed in some cancers and it has been linked to their aggressiveness26. To test whether the
inhibition of focal adhesion signalling affected cell growth under nutrient starvation, MDA-MB-231 cells were treated with
a FAK inhibitor, PF573228. Firstly, the auto-phosphorylation of FAK Tyr397 was measured in the presence of different
PF573228 concentrations, to assess the effectiveness of the inhibitor in MDA-MB-231 cells. Our results revealed that around
80% inhibition of FAK activity was achieved with 0.5µM PF573228 (Figure 5A-B). Therefore, to assess the effect of FAK
inhibition on cell growth, MD-MB-231 cells were seeded either on collagen I, Matrigel or CAF-generated CDM under complete
media or amino acid starvation in the presence of 0.5µM PF573228. Interestingly, we did not observe any significant difference
in cell number between the control group and cells treated with the FAK inhibitor, either in complete media or amino acid
deprivation (Figure 5C-E). In addition, staining for the FA protein paxillin indicated no changes in the quantity and distribution
of FAs in cells under amino acid starvation compared to the complete media, on either collagen I or Matrigel, (Figure 5F-G)
or on cross-linked matrices (Figure 5H). Taken together these data indicate that FAK-dependent signalling events following
cell-ECM interaction did not affect cell growth under amino acid starvation and ECM-dependent cell growth was predominantly
mediated by ECM internalisation followed by lysosomal degradation.
ECM-dependent cell growth was mediated by phenylalanine/tyrosine metabolism under amino acid starva-
tion
It has been previously demonstrated that laminin endocytosis resulted in an increase in intracellular amino acid levels in serum
starved epithelial cells10, therefore we hypothesised that metabolites derived from ECM internalisation and degradation would
result in changes in the metabolome. To quantify ECM-dependent differences in the intracellular metabolite content, we
performed non-targeted direct infusion mass spectrometry of MDA-MB-231 cells either on plastic, collagen I or Matrigel
under amino acid starvation. We found that the intracellular levels of several amino acids, including phenylalanine, tryptophan,
threonine, leucine, isoleucine, methionine, tyrosine and hydroxy-proline, were upregulated on ECM compared to the plastic,
and we detected 525 upregulated and 596 downregulated metabolites on collagen I (Figure 6A-B) and 173 upregulated and
177 downregulated metabolites on Matrigel (Figure S4A). Metabolomic pathway analysis revealed that phenylalanine and
tyrosine metabolism was consistently enriched in cells on collagen I and Matrigel compared to plastic under amino acid
starvation (Figure 6C and Figure S6B). Phenylalanine metabolism is composed of a series of metabolic reactions, leading
to the production of fumarate, which can enter the tricarboxylic acid (TCA) cycle, leading to energy production (Figure
6D). To confirm the upregulation of phenylalanine, tyrosine and fumarate, we measured their intracellular levels using target
ultra-performance liquid chromatography-tandem mass spectrometry in MDA-MB-231 cells grown under amino acid starvation
for 6 days and we observed that the presence of collagen I led to a significant increase in the intracellular concentration of
phenylalanine, tyrosine and fumarate, compared to the plastic (Figure 6E). We reasoned that, if the ECM supported cell growth
by promoting phenylalanine metabolism, the knock-down of a central enzyme in this pathway would inhibit ECM-dependent
cell growth under amino acid deprivation. To test this, we transiently knocked-down p-hydroxyphenylpyruvate hydroxylase
(HPD) and its paralogue p-hydroxyphenylpyruvate hydroxylase-like protein (HPDL) and we assessed cell proliferation on
plastic or collagen I, under complete media or amino acid starvation. In both cases, we observed a significant reduction in
protein expression upon siRNA transfection (Figure S6C) Strikingly, while HPD knock-down did not affect cell growth on
collagen under amino acid deprivation, the downregulation of HPDL completely abrogated cell growth (Figure 6F). Moreover,
HPD knockdown resulted in a small, but significant reduction in cell growth in complete media on collagen I and plastic, while
HPDL down-regulation did not affect cell growth on plastic (Figure S6D-E). Altogether, these data indicate that HPDL, but
not HPD, has a key role in controlling ECM-dependent cell growth under amino acid starvation.
Discussion
Breast cancer cells are embedded into a highly fibrotic microenvironment enriched in several ECM components3. Different
studies suggested that cancer cells rely on extracellular protein internalisation during starvation10–14. However, to date no
studies investigated the behaviour of invasive breast cancer cells in response to the presence of ECM under nutrient starvation.
Here, we demonstrated that ECM internalisation and lysosomal degradation provide a source of amino acids, which supports
cell growth in a phenylalanine and tyrosine metabolism-dependent manner, when invasive breast cancer cells experience
amino acid starvation (Figure 6G). Importantly, we showed that the ability to use ECM to sustain cell growth under starvation
was progressively acquired during carcinoma progression, as the ECM was unable to rescue cell growth in non-transformed
MCF10A; while Matrigel, but not collagen I, promoted the growth of non-invasive DCIS cells under glutamine, but not amino
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Figure 5. Focal adhesion signalling was not required for ECM-dependent cell growth. (A-B) MDA-MB-231 cells were suspended in
complete media containing either 0.2µM, 0.5µM, 0.7µM or 1µM PF573228 (FAK inhibitor) or DMSO (vehicle) for 30 mins. Cells were
seeded on 0.5mg/ml collagen I for 30 mins in the same media, lysed and proteins analysed by Western Blotting. The intensity of the bands
was quantified using the Lycor Odyssey technology. Values are mean ± SEM from three independent experiments. *p<0.05, **p<0.001
Kruskal-Wallis, Dunn’s multiple comparisons test. (C-E) MDA-MB-231 cells were seeded on either 2mg/ml collagen I (coll I), 3mg/ml
Matrigel, CAF-CDM or plastic under complete media or amino acid starvation for six days and treated with 0.5µM PF573228 (FAKi) or
DMSO (control) every two days. Cells were fixed and stained with Hoechst. Images were collected by ImageXpress micro and analysed by
MetaXpress software. Values are mean ± SEM from three independent experiments. (F-H) MDA-MB-231 cells were plated on 2mg/ml
collagen I (coll I) or 3mg/ml Matrigel (Matr), previously cross-linked with 10% glutaraldehyde where indicated (x-linked), for 3 days in
complete (Com) or amino acid free (AA) media, fixed and stained for paxillin (green) and nuclei (blue). Bar, 10µm. Images were acquired
with a Nikon A1 confocal microscope and quantified with Image J. Values are mean ± SEM from three independent experiments (the black
dots represent the mean of individual experiments).
acid, deprivation. Non-invasive breast cancer cells reside inside the mammary duct and are in contact with the basement
membrane, but not with stromal collagen I27. Since Matrigel is a basement membrane extract, our data suggest that DCIS cells
are only able to take advantage of basement membrane components to support their growth under starvation. Consistent with
our data in MDA-MB-231, highly invasive and metastatic MCF10CA1 cell growth was supported by the ECM under both
starvation conditions. In contrast, it was previously demonstrated that the growth of serum-starved MCF10A was promoted by
the incubation with soluble laminin10, suggesting that the role of the ECM in supporting non-trasformed epithelial cell growth
could be dependent on the type of starvation experienced by the cells. Indeed, we observed a partial rescue of MCF10A cell
growth in the presence of Matrigel under serum starvation (data not shown).
It has recently been reported that amino acid starvation induced MT1-MMP-dependent ECM degradation, through the
inhibition of MT1-MMP endocytosis28. Here, we showed that MMP inhibition did not oppose ECM internalisation and
ECM-dependent cell growth. However, Colombero et al. assessed ECM degradation within the first 24hr after amino acid
starvation28, while we focused on later time points (3 and 6 days). Therefore, it is possible that the induction of ECM
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Figure 6. ECM-dependent cell growth was mediated by tyrosine catabolism. (A-C) MDA-MB-231 cells were plated on plastic or
2mg/ml collagen I (coll I) for 6 days in amino acid-free media. Metabolites were extracted and quantified by non-targeted mass spectrometry.
Fold changes in amino acid levels (A), Volcano plot highlighting statistically significant changes in metabolites in red (B) and enriched
metabolic pathways (C) are presented. (D) Schematic representation of phenylalanine and tyrosine catabolism. (E) Metabolites were prepared
as in (A) and the levels of phenylalanine, tyrosine and fumarate were measured by targeted mass spectrometry. (F) MDA-MB-231 cells
were plated on 2mg/ml collagen I (coll I), transfected with siRNA targeting HPD (HPD siRNA), siRNA targeting HPDL (HPDL siRNA)
or non-targeting siRNA control (Nt siRNA) and cultured under amino acid (AA) starvation for 6 days. Cells were fixed and stained with
Hoechst. Images were collected by ImageXpress micro and analysed by MetaXpress software. Values are mean ± SEM and from three
independent experiments. *** p<0.001 2way ANOVA, Tukey’s multiple comparisons test. (G) Working model: invasive breast cancer cells
internalised and degraded ECM components. This upregulated phenylalanine/tyrosine catabolism, leading to an increased production of
fumarate, supporting cell proliferation under amino acid starvation. ECM, extracellular matrix; PM, plasma membrane; Lys, lysosome; Mitoc,
mitochondria.
degradation is an early response to amino acid starvation, which is not required to sustain cell proliferation at later time points.
We showed that the presence of ECM fully rescued mTORC1 activation under amino acid starvation. This is in agree-
ment with several previous studies showing that mTORC1 could be reactivated by extracellular proteins under amino acid
deficiency10, 11 through a positive feedback loop, as inhibition of mTORC1 induced extracellular protein scavenging10, 11.
Similarly, we have previously demonstrated that mTORC1 inhibition promoted fibronectin internalisation in ovarian cancer
cells12. Furthermore, our data showed that the presence of ECM elevated mTORC1 activity in starved cells to the same level
as cells in complete media, whereas, the ECM only partially rescued cell growth under starvation, indicating that growth is
still limited despite a complete activation of mTORC1. It is important to note that we used only one readout of mTORC1
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activation (S6 phosphorylation), therefore we cannot exclude the possibility that the ECM was unable to rescue other signalling
pathways downstream of mTOR. Interestingly, it has been previously shown that elevated mTORC1 activity restrains growth if
cells rely on scavenging extracellular proteins as a source of amino acids. This is because high mTORC1 activity results in
higher translation rate and cells relying on extracellular proteins cannot support the high rate of both protein translation and
growth at the same time, due to their reduced access to free amino acids. Therefore, mTORC1 reactivation resulted in lower
growth in cells using extracellular proteins as amino acid source29 . Previous literature showed that, in pancreatic cancer cells,
collagen-dependent cell growth under glucose and glutamine starvation was coupled with activation of ERK, but not mTORC1,
signalling15, suggesting that the ECM supports cell growth via triggering distinct downstream signalling pathways in different
cancer types.
By using both matrix cross-linking and the enodcytosis inhibitor filipin, we demonstrated that ECM internalisation is
required for ECM-dependent cell growth under amino acid starvation. Several pathways have been shown to control the uptake
of different ECM components23, therefore future work will characterise how ECM internalisation and lysosomal degradation
are regulated in invasive breast cancer cells.
Phenylalanine and tyrosine metabolism has been shown to be implicated several cancer types. Interestingly, a comprehensive
metabolomic study identified the upregulation of phenylalanine and tyrosine metabolism in invasive ductal carcinoma compared
to benign tumours and normal mammary tissues30. Moreover, we detected C13-fumarate when the cells were cultured in
the presence of C13-tyrosine (data not shown). HPD has been shown to be upregulated in invasive breast cancer and, to a
lesser extent, DCIS compared to normal tissues and its expression correlated with poor prognosis31. In lung cancer, high HPD
expression correlated with poor prognosis. HPD has been reported to promote cell growth in vitro and in vivo, by controlling
the flux through the pentose phosphate pathway, in a tyrosine metabolism-independent manner32. It is therefore possible that
HPD controls cell growth on plastic via a similar mechanism in our system as well. In colon adenocarcinoma cells, it has been
shown that HPDL KD reduced oxygen consumption, implying that it could play a role in controlling mitochondria functions.
Besides, in colon cancer cells, HPDL has been shown to localise to mitochondria and its KO did not result in impaired tyrosine
catabolism33, suggesting that, similarly to HPD, HPDL could be involved in multiple metabolic pathways. Interestingly, our
preliminary evidence suggest that HPDL KD resulted in reduced fumarate levels under amino acid starvation in MDA-MB-231
cells (data not shown). Future work will characterise the mechanism through which HPDL controls ECM-dependent cell
proliferation. Interestingly, preliminary observations suggest that ECM-dependent cell growth promoted HPDL expression,
while reducing HPD levels (data not shown). This raises the intriguing possibility that HPDL exerts a specific function in
controlling ECM-dependent cell growth, triggered by nutrient starvation in breast cancer tumours.
In conclusion, our findings demonstrated that, under amino acid starvation, invasive breast cancer cells, but not non-
transformed mammary epithelial cells and non-invasive DCIS cells, internalised and degraded ECM components. This resulted
in an increase in tyrosine catabolism, leading to the production of fumarate. Therefore, HPDL-mediated tyrosine catabolism
could be a metabolic vulnerability of cancer cells thriving in a nutrient-deprived microenvironment.
Methods
Reagents. Primary antibodies for Phospho-S6 Ribosomal Protein ser235/236 and GAPDH were from Cell Signalling,
Phospho-FAK (Tyr397), HPD and HPDL from Thermo Fisher, β1 integrin (clone TS2/16) from BioLegend and Paxilin from
BD-bioscience. Secondary antibodies Alexa-fluor 594 anti-Rabbit IgG, Alexa-fluor 488 anti-Rabbit IgG and Alexa-fluor 488
anti- Mouse IgG were from Cell Signalling, IRDye® 800CW and IRDye® 680CW were from LI-COR. Alexa fluor TM 555
Phalloidin, Click-iT EdU Imaging Kits, CellEventTM Caspase-3/7 Green Detection kit, NHS-Fluorescein, pH-rodo iFL STP
ester red and Hoechst 33342 were from Invitrogen. DRAQ5 was from LI-COR. Collagen I and Matrigel were from Corning.
All media and dialyzed FBS were from Gibco, except for DMEM with no amino acid which was from US Biological life
science and Plasmax which was kindly provided by Dr Tardito, CRUK Beatson Institute, Glasgow. The details of Plasmax
composition were previously described by Vande Voorde et al 201919. E64d (Aloxistatin) and PF573228 were from AdooQ
Bioscience. GM6001 was from APEXBIO. Filipin was from Sigma.
Cell culture. MDA-MB-231 cells, Telomerase immortalised normal fibroblasts (NFs) and cancer associated fibroblasts (CAFs),
generated in Professor Akira Orimo’s lab, Paterson Institute, Manchester, were cultured in High glucose Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin streptomycin (PS). MCF10A,
MCF10A-DCIS and MCF10CA1 were a kind gift from Prof Giorgio Scita, IFOM, Milan (Italy). MCF10A-DCIS cells were
cultured in DMEM/F12 supplemented with 5% Horse serum (HS), 20 ng/ml epithelial growth factor (EGF) and 1% PS.
MCF10A cells were cultured in DMEM/F12 supplemented with 5% HS, 20 ng/ml EGF, 0.5mg/ml hydrocortisone, 10µg/ml
insulin and 1% PS. MCF10CA1 cells were cultured in DMEM/F12 supplemented with 2.5% HS, 20 ng/ml EGF, 0.2mg/ml
hydrocortisone, 10µg/ml insulin and 1% PS. Cells were grown at 5% CO2 and 37
◦C and passaged every 3 to 4 days.
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ECM preparation. To coat plates/dishes, collagen I and Matrigel were diluted with cold PBS on ice to 2mg/ml and 3mg/ml
concentrations respectively and incubated for 3 hrs at 5% CO2, and 37
◦C for polymerization. Cell derived matrix (CDM)
was generated from NFs and CAFs as described in16. Briefly, plates were coated with 0.2% gelatin in PBS and incubated at
37◦C for 1 hr and cross-linked with 1% glutaraldehyde in PBS at room temperature (RT) for 30 mins. Glutaraldehyde was
removed and quenched in 1M glycine at RT for 20 mins, followed by two PBS washes, and an incubation in full media at 5%
CO2 and 37
◦C for 30 mins. CAFs or NFs were seeded and incubated at 5% CO2, 37
◦C until fully confluent. The media was
replaced with full growth media containing 50µg/ml ascorbic acid, and it was refreshed every two days. NFs were kept in
media supplemented with ascorbic acid for six days while CAFs for seven days. The media was aspirated, and the cells washed
once with PBS containing calcium and magnesium. The cells were incubated with the extraction buffer containing 20mM
NH4OH and 0.5% Triton X-100 in PBS containing calcium and magnesium for 2 mins at RT until no intact cells were visible
by phase contrast microscopy. Residual DNA was digested with 10µg/ml DNase I at 5% CO2, 37
◦C for 1 hr. The CDMs were
kept in PBS containing calcium and magnesium at 4◦C.
ECM cross-linking. The ECMs were prepared as described above and treated with 10% glutaraldehyde for 30 mins at RT,
followed by two PBS washes. The cross-linker was quenched in 1M glycine at RT for 20 mins, followed by two PBS washes.
Cross-linked ECMs were kept in PBS at 5% CO2 and 37
◦C over-night.
Starvation conditions. The media used for the starvations were supplemented with either 10% dialyzed FBS (for MDA-MB-
231 cells); 10% HS, 10µg/ml insulin and 20ng/ml EGF (for MCF10A cells); 5% HS and 20ng/ml EGF (for MCF10A-DCIS
cells) or 2.5% HS, 20 ng/ml EGF, 0.2mg/ml hydrocortisone and 10µg/ml insulin (for MCF10CA1 cells). Cells were plated in
complete media for 5 hrs, then the media was replaced with the starvation media as indicated in table 1.
Media Supplier Ref No
DMEM, high glucose, no glutamine Gibco 11960-044
DMEM, no amino acids Stratech D9800-13-USB-10L
DMEM/F-12, no glutamine Gibco 21331-020
Table 1. Starvation media.
Proliferation assays. 96-well plates were coated with 15µl/well of 2mg/ml collagen I or 3mg/ml Matrigel. Three wells of
96-well plate were allocated to each condition as technical replicates. 103 cells/well (MDA-MB-231, MCF10A, MCF10A-
DCIS cells) or 400 cells/well (MCF10CA1) were seeded in complete growth media. After a 5 hr incubation in 5% CO2 and
37◦C, the media was replaced with 200µl of the starvation media, in the presence of 10µM GM6001, 0.5µM PF573228,
5µg/ml filipin or DMSO control where indicated. The inhibitors were supplemented every two days, up to day 6. Cells
were fixed every two days up to day six or eight by adding 4% paraformaldehyde (PFA) for 15 mins at RT followed by
two PBS washes. Cells were stained with either DRAQ5 or Hoechst. 5µM DRAQ5 in PBS was added to the cells for 1
hr at RT with gentle rocking. Cells were washed twice with PBS for 30 mins to avoid background fluorescence and kept
in PBS for imaging. DRAQ5 was detected by the 700nm channel with 200µm resolution with an Odyssey Sa instrument.
The signal intensity (total intensity minus total background) of each well was quantified with Image Studio Lite software.
Alternatively, cells were fixed with 4% PFA containing 10µg/ml Hoechst 33342 for 15 mins, followed by two PBS washes.
Images were acquired by ImageXpress micro with a 2x objective and the whole area of each well was covered. The images
were analysed with MetaXpress and Costume Module Editor software (CME) in the Sheffield RNAi Screening Facility
(SRSF). CAF/NF-CDM was generated in 96-well plates and cells were seeded as described above. Cells were fixed with
4% PFA containing 10µg/ml Hoechst 33342 for 15 mins, washed twice with PBS, permeabilized with 0.25% Triton X-100
for 5 mins and stained with Phalloidin Alexa Fluor 488 (1:400 in PBS) for 30 mins. Cells were washed twice with PBS
and were left in PBS for imaging. Images were collected by ImageXpress micro and analysed by MetaXpress and CME software.
EdU incorporation essays. 96-well plates were coated with ECM and 103 MDA-MB-231 cells/well were seeded in full
growth media. After a 5 hr incubation at 5% CO2 and 37
◦C, the full growth media was replaced with 200µl of the starvation
media. At day six post starvation, cells were incubated with 5µM EdU for 2 days at 5% CO2 and 37
◦C, fixed with 4% PFA
containing 10µg/ml Hoechst 33342 for 15 mins at RT and permeabilised with 0.25% Triton X-100 for 5 mins. Cells were
incubated with EdU detection cocktail (Invitrogen, Click-iT EdU Alexa Fluor 555) for 30 min at RT with gentle rocking. Cells
were washed twice with PBS and were kept in PBS for imaging. Images were collected by ImageXpress micro with a 2x
objective and quantified with MetaXpress and CME software.
Caspase-3/7 detection. 96-well plates were coated with ECM and 103 MDA-MB-231 cells/well were seeded in full growth
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media. After a 5 hr incubation at 5% CO2 and 37
◦C, the full growth media was replaced with 200µL of the starvation media.
Cells were kept under starvation for 3 or 8 days, then the media were replaced by 5µM CellEvent™ Caspase-3/7 Green
Detection Reagent diluted in PBS, containing calcium and magnesium, and 5% dyalised FBS for 1.5 hrs at 5% CO2 and 37
◦C.
Cells were fixed with 4% PFA containing 10µg/ml Hoechst 33342 for 15 mins at RT, washed and left in PBS for imaging.
Images were collected by ImageXpress micro with a 10x objective and analysed with MetaXpress and CME software.
Immunofluorescence. 103 MDA-MB-231 cells/well were seeded in full growth media in 96-well plates were coated with
ECM. After a 5 hr incubation at 5% CO2 and 37
◦C, the full growth media was replaced with 200µL of the starvation media.
After 3 days, cells were fixed with 4% PFA containing 10µg/ml Hoechst 33342 for 15 mins at RT and permeabilised with
0.25% Triton X-100 for 5 mins. Unspecific binding sites were blocked by incubating with 3% BSA at RT with gentle rocking
for 1 hr. Cells were incubated with anti-Phospho-S6 Ribosomal protein antibody (1:100 in PBS) overnight at 4◦C. The cells
were washed twice with PBS for 5 to 10 mins and incubated with secondary antibody (anti-Rabbit IgG Alexa Fluor 594, 1:1000
in PBS) for 1hr at RT with gentle rocking. Cells were washed twice with PBS for 10 to 30 mins and were kept in PBS for
imaging. Images were collected by ImageXpress micro with a 10x objective and analysed with MetaXpress and CME software.
4x104 MDA-MB-231 cells were seeded on ECM coated 3.5cm2 glass-bottomed dishes and incubated at 5% CO2 and 37
◦C
for 5 hrs. The full growth media was then replaced with the starvation media. After three days, cells were fixed with 4% PFA
for 15 mins and permeabilized with 0.25% Triton-x100 for 10mins, followed by 1hr incubation in 3% BSA (blocking buffer).
Cells were incubated with anti-mouse Paxillin primary antibody (1:200 in PBS) at RT for 1 hr. Cells were washed three times
with PBS for 20 mins and incubated with Alexa-Fluor 488 anti-Mouse IgG secondary antibody (1:1000 in blocking buffer) for
1 hr at RT with gentle shaking and protected from light. 2-3 drops of Vectashield mounting medium containing DAPI were
added to the dishes, which were then sealed with parafilm and kept at 4◦C. Cells were visualised by confocal microscopy using
a Nikon A1 microscope and 60x 1.4NA oil immersion objective. The focal adhesion index was calculated dividing the area
covered by the paxillin staining with the total cell area.
ECM uptake. 3.5cm2 glass-bottomed dishes were coated with 1mg/ml collagen I or 3mg/ml Matrigel and incubated at 5%
CO2, and 37
◦C for 3 hrs. ECMs were cross-linked where indicated and labelled with 10µg/ml NHS-Fluorescein for 1 hr at RT
on a gentle rocker. 105 MDA-MB-231 cells per dish were seeded in full growth media. After a 5 hr incubation in 5% CO2 and
37◦C, full growth media were replaced with 1ml of the indicated starvation media in the presence of 20µM E64d or DMSO.
E64d and DMSO were added after two days and cells were fixed at day three by adding 4% PFA for 15 mins at RT. Cells were
permeabilised with 0.25% Triton X-100 for 5 mins and incubated with Phalloidin Alexa Fluor 555 (1:400 in PBS) for 10 mins.
2-3 drops of Vectashield mounting medium containing DAPI were added to the dishes, which were then sealed with parafilm
and kept at 4◦C. Cells were visualised by confocal microscopy using a Nikon A1 microscope and 60x 1.4NA oil immersion
objective. Alternatively, 104 MDA-MB-231 cells/well were seeded on pH-rodo labelled 0.5mg/ml Matrigel (in 384-well plates)
in the presence of DMSO control, 2.5µg/ml or 5µg/ml filipin for 6 hrs, fixed with 4% PFA for 10 min and incubated with
anti-β1 integrin antibody conjugated with Alexa Fluor 488 for 1 hr. Cells were incubated with 10µg/ml Hoechst and left in
PBS for imaging. Images were collected with a 63x water immersion objecctive with an Opera Phenix microscope and analysed
with Columbus software. ECM uptake was quantified as described in34.
Western Blotting. MDA-MB-231 cells were trypsinized and 106 cells were collected in each Falcon tube. Cells were treated
with 0.2, 0.5, 0.7 and 1µM P573228 for 30 mins at 5% CO2 and 37
◦C, while they were kept in suspension. Cells were
transferred to a 6-well plate which had been coated with 900µL of 0.5mg/ml collagen I. Cells were allowed to adhere for 30
mins at 5% CO2 and 37
◦C. The media was aspirated, and cells were put on ice. After two washes with ice-cold PBS, 100µl
per well of lysis buffer (50mM Tris pH 7 and 1% SDS) were added. Lysates were collected and transferred to QiaShredder
columns, which were spun for 5 mins at 6000rpm. The filter was discarded, and the extracted proteins were loaded into 12%
acrylamide gels and run at 100V for 2.5 hrs. Proteins were transferred to FL-PVDF membranes in transfer buffer for 75 mins at
100V. Membranes were washed three times with TBS-T (Tris-Buffered Saline, 0.1% Tween) and blocked in 5% w/v skimmed
milk powder in TBS-T for 1 hr at RT. Membranes were then incubated with primary antibodies, 1:500 GAPDH and 1:1000
pFAK in TBS-T + 5%w/v skimmed milk overnight at 4◦C. Membranes were washed three times in TBS-T for 10 mins on the
rocker at RT. Membranes were incubated with secondary antibodies, IRDye® 800CW anti-mouse IgG for GAPDH (1:30,000)
and IRDye® 680CW anti-rabbit IgG for pFAK (1:20,000) in TBS-T + 0.01% SDS, for 1 hr at RT on the rocker. Membranes
were washed three times in TBS-T for 10 min on the rocker at RT followed by being rinsed with water. Images were taken by a
Licor Odyssey Sa system. Band intensity was quantified with Image Studio Lite software.
Non-targeted metabolite profiling. MDA-MB-231 cells were seeded on 96-well plates coated with ECM under full growth
media. After a 5 hr incubation at 5% CO2 and 37
◦C, the full growth media was replaced with the starvation media. After 6
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days, the media was removed, and cells were washed with ice-cold PBS three times. The PBS were aspirated very carefully
after the last wash to remove every remaining drop of PBS. The extraction solution (cold; 5 MeOH: 3 AcN: 2 H2O) was added
for 5 mins at 4◦C with low agitation. Metabolites were transferred to eppendorf tubes and centrifuged at 4◦C at 14000 rpm
for 10 mins. Samples were transferred into HPLC vials and directly injected into a Waters G2 Synapt mass spectrometer in
electrospray mode within the Sheffield Faculty of Science Biological Mass Spectrometry Facility. The samples were run in
positive and negative modes. Three technical replicates of each sample were run. The dataset only includes peaks present in all
three replicates. The data is binned into 0.2amu m/z bins and the m/z in each bin is used to identify putative IDs using the
HumanCyc database. The mass spectrometry data were analysed using Perseus software version 1.5.6.0. Metabolic pathway
analysis was performed with https://www.metaboanalyst.ca/, p<0.05.
Targeted metabolomics. MDA-MB-231 cells were seeded on 6-well plates coated with ECM in full growth media. After
a 5 hr incubation at 5% CO2 and 37
◦C, full growth media was replaced with amino acid-free media. Cells were kept under
starvation for six days, the media was removed and metabolites were extracted as described above. Then, a mass spectrometer
Waters Synapt G2-Si coupled to Waters Acquity UPLC was used to separate phenylalanine, tyrosine and fumaric acid with
Column Waters BEH Amide 150x2.1mm. The injection was 10µl. The flow rate was 0.4ml/min. The samples were run in
negative mode. To identify the targeted metabolites, the retention time and the mass of the compound were matched with the
standards.
Transfection. Glass-bottomed 96-well plates were coated with 15µ l 2mg/ml collagen I and 20µ l of 150nM ON TARGET plus
Human HPDL and HPD smart pool were added on each well. 0.24µ l of Dharmafect 1 (DF1) was diluted in 19.86µ l of DMEM.
20µ l of diluted DF1 were transferred to each well. Plates were incubated for 30 mins at RT. 3×103 cells in 60µ l DMEM media
containing 10% FBS but no antibiotics were seeded in each well. The final concentration of siRNA was 30nM. Cells were
kept at 5% CO2 and 37
◦C over-night. The full growth media was replaced by 200µ l of fresh complete or amino acid-depleted
media for up to 6 days. At day 2 and 6, cells were fixed and incubated with 10µg/ml Hoechst 33342. Images were collected by
ImageXpress micro and analysed by MetaXpress and CME software.
Statistical analysis. Graphs were created by GraphPad Prism software (version 9) as super-plots, where single data points
from individual experiment are presented in the same shade (grey, maroon and blue) and the mean is represented by black dots.
To compare more than two data set, one-way ANOVA (Kruskal-Wallis, Dunn’s multiple comparisons test) was used when there
was one independent variable. Two-way ANOVA (Tukey’s multiple comparisons test) was performed when there were two
independent variables. Statistical analysis for non-targeted metabolic profiling was performed by Perseus software and used
Student t-test (SO = 0.1 and false discovery rate (FDR) = 0.05).
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